Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Gillian Flaccus, Associated Press
PORTLAND, Ore. — Green Thumb Industries had a business plan, expertise and plenty of ambition to grow its marijuana business. What the Chicago-based company didn't have was access to enough capital to make it all happen.
By Michael Balsamo, Associated Press
Legal pot shops are losing customers who can get products more cheaply at illegal outlets that don't charge or pay taxes.
By Brian Melley, Associated Press
LOS ANGELES — Bargain basement bud is on the menu in California, but you need to act fast to cash in on the cheap weed.
By Matthew Perrone, Associated Press
The Food and Drug Administration approved the medication from GW Pharmaceuticals on Monday to treat two rare forms of childhood epilepsy. It's a milestone that could spur more research into a drug that remains illegal under federal law.
By Rob Gillies, Associated Press
Canada's Senate gave final passage Tuesday to the federal government's bill to legalize cannabis.
By PBS NewsHour
On this edition for Sunday, June 17, a policy of separating immigrant children from their parents at the border draws condemnation, and the surprising source of medical marijuana in Italy. Also, unearthing the unlikely love story of a nurse and…
Italy’s lone medical marijuana facility is controlled by the military, which officials say helps prevent patients from buying it on the black market. However, the government's yield can't keep up with an increasing demand, creating a shortages for cancer patients…
By Michael R. Blood, Associated Press
The legislation would ensure states have the right to determine the best approach to marijuana within their borders, but some U.S. restrictions would remain, including recreational sales to people under 21.
PORTLAND, Ore. — When Oregon lawmakers created the state's legal marijuana program, they had one goal in mind above all else: to convince illicit pot growers to leave the black market.
The Food and Drug Administration posted its review Tuesday of the experimental medication ahead of a public meeting later this week.
Support Provided By: